Biotechnology News

KØBENHAVN, Danmark, 2. november 2026 – Bavarian Nordic A/S (OMX: BAVA) meddeler, at aktietilbagekøbsprogrammet, der blev offentliggjort og iværksat den 1. september 2026, nu er afsluttet, da aktier...

GENFIT to Highlight Progress in ACLF and MASH Diagnostics at AASLD The Liver Meeting® 2026

GENFIT présentera ses avancées dans l’ACLF et dans le diagnosticde la MASH lors du congrès AASLD The Liver Meeting® 2026

COPENHAGEN, Denmark, November 2, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced that it has been awarded a new multi-year contract by the UK Government through the UK Health Security Agency...

KØBENHAVN, Danmark, 2. november 2026 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at selskabet har indgået en ny flerårig kontrakt med den britiske regering gennem UK Health Security Agency...

MALVERN, Pa., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral...

Dyadic to Report Q3 2026 Financial Results and Host Conference Call on Thursday November 12, 2026

TME Pharma Publishes Its Semi Annual Results and Half-Year Report Berlin, Germany, October 30, 2026, 18:00 CET – TME Pharma N.V. (Euronext Growth Paris: ALTME), a biotech-company with clinical assets...

TME Pharma publie ses résultats semestriels et son rapport semestriel Berlin, Allemagne, le 30 octobre 2026, 18 h 00 CET – TME Pharma N.V. (Euronext Growth Paris : ALTME), une société de...

First FDA-approved biologic specifically designed to cross blood-brain barrier wins award dedicated to exceptional scientific leadership and transformational impact on patient careFirst new...